John Gordon Freund

CIK: 0001296771

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (45.5%)

Position reduction

Option Exercises (M)2 (18.2%)

Derivative conversions

Awards (A)4 (36.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

SIBN

SI-BONE, Inc.

Director

COLL

COLLEGIUM PHARMACEUTICAL, INC

Director

Discretionary Trading P&L

Holdings

Transaction History (11 total)

SIBN
SI-BONE, Inc.
Jun 4, 2026
Award(A)
Direct
11K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
May 18, 2026
Sale(S)
Direct
20 shares at avg. $34.05$681
COLL
COLLEGIUM PHARMACEUTICAL, INC
May 15, 2026
Exercise(M)
Direct
8.7K shares at avg. $16.49$143K
COLL
COLLEGIUM PHARMACEUTICAL, INC
May 15, 2026
Sale(S)
Direct
4.1K shares at avg. $34.54$143K
COLL
COLLEGIUM PHARMACEUTICAL, INC
May 14, 2026
Award(A)
Direct
8.7K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
Aug 8, 2025
Sale(S)
Indirect
11.7K shares at avg. $34.36$401K
SIBN
SI-BONE, Inc.
Aug 8, 2025
Sale(S)
Indirect
12.1K shares at avg. $15.99$194K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Jun 9, 2025
Exercise(M)
Direct
15K shares at avg. $13.45$202K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Jun 9, 2025
Sale(S)
Direct
6.6K shares at avg. $30.62$202K
SIBN
SI-BONE, Inc.
Jun 5, 2025
Award(A)
Direct
8.7K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
May 15, 2025
Award(A)
Direct
9.8K shares-

		Type	Shares	Price		Ownership
Jun 4, 2026	SIBN SI-BONE, Inc.	Award(A)	10,957	-	$0	Direct
May 18, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	20	$34.05	$681	Direct
May 15, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Exercise(M)	8,700	$16.49	$143,463	Direct
May 15, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	4,127	$34.54	$142,547	Direct
May 14, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Award(A)	8,741	-	$0	Direct
Aug 8, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	11,659	$34.36	$400,641	Indirect
Aug 8, 2025	SIBN SI-BONE, Inc.	Sale(S)	12,132	$15.99	$193,998	Indirect
Jun 9, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Exercise(M)	15,000	$13.45	$201,750	Direct
Jun 9, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	6,601	$30.62	$202,149	Direct
Jun 5, 2025	SIBN SI-BONE, Inc.	Award(A)	8,675	-	-	Direct
May 15, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Award(A)	9,791	-	-	Direct

1-11 of 11 transactions

About Freund John Gordon

Freund John Gordon (SEC CIK 0001296771) files insider reports with the SEC as Director of SI-BONE, Inc. (SIBN) and Director of COLLEGIUM PHARMACEUTICAL, INC (COLL).

Signal8 holds 8 ownership filings by Freund John Gordon, all Form 4s, filed between May 19, 2025 and Jun 8, 2026. Those filings report 11 transactions, from May 15, 2025 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Freund John Gordon's filings is in SANTA CLARA, CA.

Recent filings by Freund John Gordon

Jun 4, 2026: Grant or award of SIBN shares (Form 4, code A).
May 18, 2026: Open-market sale of COLL shares (Form 4, code S).
May 15, 2026: Option exercise of COLL shares (Form 4, code M).
May 15, 2026: Open-market sale of COLL shares (Form 4, code S).
May 14, 2026: Grant or award of COLL shares (Form 4, code A).

Other insiders filing for SI-BONE, Inc. (SIBN)

PISETSKY MICHAEL A., SVP, Ops & Adm/Chief Legal Ofr
Maheshwari Anshul, Chief Op & Financial Officer
FRANCIS LAURA, Chief Executive Officer
DUNN JEFFREY W, Director
HILLEMAN JERYL L, Director
Nishimura Mika, Director

How to read Form 4 transaction codes